(Q37668623)

21 August 2017

1 reference

title

Tagatose: from a sweetener to a new diabetic medication? (English)

1 reference

21 August 2017

Ikna Espinosa

1

1 reference

PubMed ID

20050825

21 August 2017

Leon Fogelfeld

series ordinal

2

1 reference

PubMed ID

20050825

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Investigational Drugs

21 August 2017

1 reference

21 August 2017

19

1 reference

21 August 2017

2

1 reference

21 August 2017

285-294

1 reference

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Tagatose, the new GRAS sweetener and health product

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

D-tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Human gastrointestinal tolerance to D-tagatose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

D-tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Resveratrol blocks high glucose-induced mitochondrial reactive oxygen species production in bovine aortic endothelial cells: role of phase 2 enzyme induction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

A distinct D-fructose transport system in isolated brush border membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Stimulation of glucose phosphorylation by fructose in isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

90-Day oral toxicity study of D-tagatose in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Control of glucokinase translocation in rat hepatocytes by sorbitol and the cytosolic redox state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Investigation on the mechanism by which fructose, hexitols and other compounds regulate the translocation of glucokinase in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Integrated effects of multiple modulators on human liver glycogen phosphorylase a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Effect of D-tagatose on liver weight and glycogen content of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Characteristics and significance of D-tagatose-induced liver enlargement in rats: An interpretative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Effect of oral D-tagatose on liver volume and hepatic glycogen accumulation in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Effects of acute and repeated oral doses of D-tagatose on plasma uric acid in normal and diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Targeting prandial hyperglycemia: how important is it and how best to do this?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903501521

10.1517/13543780903501521

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

20050825